Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H6OS |
Molecular Weight | 78.1346 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)C
InChI
InChIKey=IAZDPXIOMUYVGZ-UHFFFAOYSA-N
InChI=1S/C2H6OS/c1-4(2)3/h1-2H3
Dimethyl sulfoxide (DMSO) is a clear odorless liquid, inexpensively produced as a by-product of the paper industry. It is widely available in the USA as a solvent but its medical use is currently restricted by the FDA to the palliative treatment of interstitial cystitis and to certain experimental applications. In medicine, DMSO is also used as a topical analgesic, a vehicle for topical application of pharmaceuticals, as an anti-inflammatory, and an antioxidant.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | RIMSO-50 Approved UseRIMSO-50 (dimethyl sulfoxide) is indicated for the symptomatic relief of patients with interstitial cystitis. RIMSO-50 has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract. Launch Date2.60409606E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Pentachlorophenol potentiates benzo[a]pyrene DNA adduct formation in adult but not infant B6C3F1 male mice. | 2001 |
|
Viral delivery of superoxide dismutase gene reduces cyclosporine A-induced nephrotoxicity. | 2001 Apr |
|
Exposure of neonatal female rats to p-tert-octylphenol disrupts afternoon surges of luteinizing hormone, follicle-stimulating hormone and prolactin secretion, and interferes with sexual receptive behavior in adulthood. | 2001 Apr |
|
Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. | 2001 Apr |
|
Transcriptional activation of prion protein gene in growth-arrested and differentiated mouse erythroleukemia and human neoplastic cells. | 2001 Apr 1 |
|
Enzymic characterization of epidermis-derived 12-lipoxygenase isoenzymes. | 2001 Apr 1 |
|
The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. | 2001 Apr 13 |
|
An active site tyrosine influences the ability of the dimethyl sulfoxide reductase family of molybdopterin enzymes to reduce S-oxides. | 2001 Apr 20 |
|
Influence of N-terminal residue stereochemistry on the prolyl amide geometry and the conformation of 5-tert-butylproline type VI beta-turn mimics. | 2001 Feb |
|
Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes. | 2001 Feb |
|
Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer. | 2001 Feb |
|
[Ring cleavage of N-arylpyridinium salts by nucleophiles--regioselectivity and stereochemistry of the products. 1]. | 2001 Feb |
|
Comparison of cryoprotectants in the preservation of Theileria parva sporozoites using an in vitro infectivity assay. | 2001 Feb |
|
Characterization of northern pintail (Anas acuta) ejaculate and the effect of sperm preservation on fertility. | 2001 Feb |
|
Quality control of refrigerated and cryopreserved semen using computer-assisted sperm analysis (CASA), viable staining and standardized fertilization in African catfish (Clarias gariepinus). | 2001 Feb 1 |
|
Electronic spectral studies of molybdenyl complexes. 2. MCD spectroscopy of [MoOS4]- centers. | 2001 Feb 12 |
|
Systematic structural coordination chemistry of p-tert-butyltetrathiacalix[4]arene: 1. Group 1 elements and congeners. | 2001 Feb 12 |
|
Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. | 2001 Feb 16 |
|
Synthesis, crystal structure, spectral studies, and catechol oxidase activity of trigonal bipyramidal Cu(II) complexes derived from a tetradentate diamide bisbenzimidazole ligand. | 2001 Feb 26 |
|
In vitro culture and synchronous release of Sarcocystis neurona merozoites from host cells. | 2001 Feb 26 |
|
Sex steroid receptor regulation by genistein in the prepubertal rat uterus. | 2001 Feb 28 |
|
Crystal structure of the 100 kDa arsenite oxidase from Alcaligenes faecalis in two crystal forms at 1.64 A and 2.03 A. | 2001 Feb 7 |
|
Comparison of Unisol with Euro-Collins solution as a vehicle solution for cryoprotectants. | 2001 Feb-Mar |
|
Mechanical and histological characteristics of human trachea before and after cryopreservation: an opportunity for tracheal tissue banking. | 2001 Feb-Mar |
|
[DNA repair if mucous membrane cells and lymphocytes with the comet assay]. | 2001 Jan |
|
Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells. | 2001 Jan |
|
[Study on the effects of DNA damage induced by cigarette smoke in male mice testicular cells using comet assay]. | 2001 Jan |
|
Oxidation of gas mixtures containing dimethyl sulfide, hydrogen sulfide, and methanethiol using a two-stage biotrickling filter. | 2001 Jan |
|
Differentiation of stromal-vascular cells isolated from canine adipose tissues in primary culture. | 2001 Jan |
|
Electron and video-light microscopy analysis of the in vitro effects of pyrantel pamoate on Giardia lamblia. | 2001 Jan |
|
Biohybrid microarrays--impedimetric biosensors with 3D in vitro tissues for toxicological and biomedical screening. | 2001 Jan 1 |
|
Bioaccumulation of polychlorinated biphenyls (PCBs) and dichlorodiphenylethane (DDE) methyl sulfones in tissues of seal and dolphin morbillivirus epizootic victims. | 2001 Jan 12 |
|
Cryopreservation of equine embryos by open pulled straw, cryoloop, or conventional slow cooling methods. | 2001 Jan 15 |
|
A low-power, atmospheric pressure, pulsed plasma source for molecular emission spectrometry. | 2001 Jan 15 |
|
Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection. | 2001 Jan-Feb |
|
Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism. | 2001 Mar |
|
Ran stimulates spindle assembly by altering microtubule dynamics and the balance of motor activities. | 2001 Mar |
|
Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. | 2001 Mar |
|
In-vitro growth of murine pre-antral follicles after isolation from cryopreserved ovarian tissue. | 2001 Mar |
|
New agents for the medical treatment of interstitial cystitis. | 2001 Mar |
|
Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent. | 2001 Mar |
|
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry. | 2001 Mar 1 |
|
Anion recognition by thiostrepton. | 2001 Mar 12 |
|
Determination of an optimal potential window for catalysis by E. coli dimethyl sulfoxide reductase and hypothesis on the role of Mo(V) in the reaction pathway. | 2001 Mar 13 |
|
Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. | 2001 Mar 23 |
|
Photochemical and chemical oxidation of alpha-dimine-dithiolene metal complexes: insight into the role of the metal atom. | 2001 Mar 26 |
|
Syntheses of hydrated molybdenum bronzes by reduction of MoO3 with NaBH4. | 2001 Mar 26 |
|
Synthesis of novel 2-azabicyclo[2.2.0]- and [2.1.1]hexanols. | 2001 Mar 9 |
|
NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. | 2001 May |
|
Dimethyl sulfoxide affects the selection of splice sites. | 2001 May 18 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/dosage/dimethyl-sulfoxide.html
Usual Adult Dose for Cystitis
Interstitial cystitis:
Instill 50 mL of dimethyl sulfoxide into the bladder by catheter or Asepto syringe. Allow to remain for 15 minutes. The medication is expelled by spontaneous voiding.
Maintenance dose: Repeat every 2 weeks until maximum symptomatic relief obtained
Duration of therapy: Time intervals between therapy may be increased appropriately
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
M02AX03
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
CFR |
21 CFR 524.660
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
EPA PESTICIDE CODE |
177
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
FDA ORPHAN DRUG |
108697
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
FDA ORPHAN DRUG |
254707
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
WHO-VATC |
QG04BX13
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
WHO-VATC |
QM02AX03
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
FDA ORPHAN DRUG |
81394
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
CFR |
21 CFR 524.981E
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
WHO-VATC |
QM02AX53
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
NCI_THESAURUS |
C45496
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
WHO-ATC |
G04BX13
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
FDA ORPHAN DRUG |
14986
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
EU-Orphan Drug |
EU/3/05/263
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
FDA ORPHAN DRUG |
104097
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
CFR |
21 CFR 524.981D
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
||
|
JECFA EVALUATION |
METHYLSULFINYLMETHANE
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3455
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | RxNorm | ||
|
906
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
M4555
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | Merck Index | ||
|
YOW8V9698H
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
1211006
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | USP-RS | ||
|
D004121
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
DB01093
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
67-68-5
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
200-664-3
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
C437
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
80
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
DIMETHYL SULFOXIDE
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
2023
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
67-68-5
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
SUB07176MIG
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
CHEMBL504
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY | |||
|
679
Created by
admin on Fri Jun 25 20:54:36 UTC 2021 , Edited by admin on Fri Jun 25 20:54:36 UTC 2021
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)